REUTERS
September 16, 2020 at 11:42 JST
SEOUL--South Korea aims to secure a supply of novel coronavirus vaccines for 30 million people, or 60 percent of its population, Prime Minister Chung Sye-kyun said on Tuesday.
While authorities would like to inoculate the entire population of 52 million, uncertainty around any vaccine’s safety, efficacy and development was limiting South Korea’s investment, Chung told a cabinet meeting.
Global vaccine makers are racing to develop an effective vaccine against the virus that has killed more than 925,000 people since it emerged in China late last year.
Chung said the government would negotiate with relevant international organizations and vaccine makers to secure the supply and would buy more as developments unfolded.
In August, South Korea said it planned to join the COVAX facility, a global novel coronavirus vaccine allocation plan co-led by the World Health Organization (WHO), which aims to help buy and fairly distribute the shots.
South Korea will buy 20 million doses of vaccine from the COVAX scheme, enough for 10 million people, and 40 million doses from private drug-makers, health authorities said in a statement.
The government has prepared 172 billion won ($146 million) to pay for vaccines, including $70 million for the 20 million doses from the COVAX facility.
"We will prepare to secure the safest and proven-effective vaccines as of now to inoculate as many as possible," a Korea Disease Control and Prevention Agency (KDCA) official, Kwon Jun-wook, told a briefing.
South Korea has been one of the world’s coronavirus mitigation success stories, with an aggressive testing and tracing strategy, but it has nevertheless been battling persistent spikes in infections.
The KDCA reported 106 new coronavirus cases as of Monday, bringing its total number of infections to 22,391 with 367 deaths.
South Korea’s SK Bioscience in July agreed to manufacture AstraZeneca’s experimental vaccine, which has shown promise, to help the British company build global supplies.
Novavax Inc. last month separately said SK Bioscience, a unit of SK Chemicals, would manufacture a component of the U.S. drug developer’s experimental coronavirus vaccine in a bid to boost its supply.
Indonesia books 40 million coronavirus vaccine doses from Sinovac
August 21, 2020
Pfizer, BioNTech to supply 120 mln doses of coronavirus vaccine to Japan
August 1, 2020China’s CNBG, Sinovac find more countries to test coronavirus vaccines
September 7, 2020
Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine
August 28, 2020
Group says 76 nations, including Japan, committed to vaccine access plan
September 4, 2020
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series about Japanese-Americans and their memories of World War II
